Vycor Medical, Inc Appoints Lowell Rush as Independent Director and Chairman of Audit Committee
May 03, 2013 at 06:00 pm IST
Share
Vycor Medical Inc. announced the appointment of Lowell Rush as independent director and Chairman of a newly-formed Audit Committee. At the same time Heather Vinas, who has remained on the Board since stepping down as President in May 2010, will depart the Board. Mr. Rush, has experience in financial management and operational development, and is currently Chief Operating Officer of Cosmetic Dermatology Inc. Previously, he held positions as CFO of Bijoux Terner, LLC; CFO of Little Switzerland, Inc; and VP Sales Operations of Rewards Network Inc.
Vycor Medical, Inc. provides surgical and therapeutic solutions. The Company designs, develops and markets neurological medical devices and therapies. The Company operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment designs, develops and markets medical devices for use in neurosurgery. The NovaVision segment provides non-invasive rehabilitation therapies for those who have vision disorders resulting from neurological brain damage such as that caused by a stroke. Vycor Medical's product Vycor Medical's ViewSite Brain Access System (VBAS) is a next generation retraction and access system. Vycor Medical focuses on brain and cervical surgical access systems for sale to hospitals and medical professionals. NovaVision's products include Vision Restoration Therapy (VRT), NeuroEyeCoach and Neuro-Eye Therapy (NeEt). The Company operates in the United States and Europe.